Boston Scientific stock at EUR 37.75 with P/ E 17.2
Published on 10/09/2026 at 20:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Boston Scientific stock was at EUR 37.75 at Lang & Schwarz on October 9, 2026, up 0.75 percent from EUR 37.47.
- The stock's primary-market quote was USD 42.27, with a 52-week range of USD 41.39 to USD 105.65.
- Market capitalization was USD 62.8 billion and P/E was 17.20.
- Boston Scientific is scheduled to report third-quarter 2026 results on October 28, 2026, before the market opens.
Boston Scientific stock was trading at EUR 37.75 at Lang & Schwarz on October 9, 2026 at 8:15 p.m. CEST, plus 0.75 percent versus the prior close of EUR 37.47. The valuation snapshot puts the P/E ratio at 17.20, while the NYSE quote stood at USD 42.27 at 2:16 p.m. ET.
Volume stays below average
Trading volume reached 6,123,010 shares on October 9, 2026, against an average of 19,873,014 shares. That puts the session volume 69.19 percent below its average, a measurable sign that the latest price level has not been accompanied by typical turnover.
The primary-market quote remained close to the 52-week low of USD 41.39 and well below the high of USD 105.65. At USD 42.27, the share price was USD 0.88, or 2.13 percent, above the low on the same date.
Quarterly growth remains measurable
Boston Scientific reported revenue of USD 5.44 billion in the second quarter of 2026, up 7.50 percent from the same quarter a year earlier, according to MarketBeat. The comparison gives the current market value a concrete operating reference, even as the share remains close to its yearly low.
Valuation and analyst targets
Market capitalization was USD 62.8 billion on October 9, 2026, and the P/E ratio was 17.20. Barclays raised its rating to Hold in a note dated October 7, 2026 and set a USD 48.00 price target, as reported by Business Insider.
Comparison with peers
Boston Scientific: plus 0.75 percent, P/E 17.20, market capitalization USD 62.8 billion
Medtronic (NYSE, USD): plus 0.60 percent, P/E 21.72, market capitalization USD 113.0 billion
Abbott Laboratories (NYSE, USD): plus 0.61 percent, P/E 31.90, market capitalization USD 171.5 billion
Next results date is set
Boston Scientific is scheduled to report third-quarter 2026 results on October 28, 2026, before the market opens, with the conference call set for 8:00 a.m. ET, according to MarketBeat. Analysts cited on the same page expect USD 0.76 in earnings per share and USD 5.13 billion in revenue for the quarter, both measured against the second quarter's reported figures.
Boston Scientific stock after hours
Boston Scientific stock was trading at EUR 37.75 at Lang & Schwarz on October 9, 2026 at 8:15 p.m. CEST, plus 0.75 percent versus the Lang & Schwarz prior close of EUR 37.47. The NYSE quote was USD 42.27 at 2:16 p.m. ET on the same date.
The further course of trading is shown by the continuously updated real-time quote of Boston Scientific stock.
Boston Scientific stock facts
- Company: Boston Scientific Corporation
- ISIN: US1011371077
- Ticker: BSX
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 9, 2026, 8:15 p.m. CEST): EUR 37.75
- Change versus prior close: plus 0.75 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 37.47
- Market capitalization: USD 62.8 billion (as of October 9, 2026)
- 52-week range: USD 41.39-105.65 (as of October 9, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: S&P 500
- Next earnings date: October 28, 2026
Market context: Market report S&P 500.
